A revolution in healthcare: Challenges and opportunities for personalized medicine

Personalized Medicine

Volumn 9, Issue 2, 2012, Pages 105-108

  Lehrach, Hans ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

genomics; health technologies; ICT; modeling; personalized medicine; pharmacogenomics; sequencing; systems biology

Indexed keywords

GENOME; HEALTH CARE; HEALTH CARE COST; HUMAN; INFORMATION TECHNOLOGY; NOTE; PATIENT MONITORING; PERSONALIZED MEDICINE; PHARMACEUTICAL CARE; PHARMACOGENOMICS; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REIMBURSEMENT; RESPONSIBILITY; SIMULATION;

EID: 84858402950     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.12.9     Document Type: Note

References (6)

1. Naidoo N, Pawitan Y, Soong R, Cooper DN, Ku CS. Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum. Genomics 5(6), 577-622 (2011).
2. Pilloni V, Atzori L. Deployment of distributed applications in wireless sensor networks. Sensors (Basel) 11(8), 7395-7419 (2011).
3. Liou SY, Stringer F, Hirayama M. The impact of pharmacogenomics research on drug development. Drug Metab. Pharmacokinet. doi:10.2133/dmpk.DMPK-11-RV-093 (2012) (Epub ahead of print).
4. Lehrach H, Subrak R, Boyle P et al. ITFoM - the IT Future of Medicine. Procedia Comput. Sci. 7(0), 26-29 (2011).
5. Mardis ER. Anticipating the 1,000 dollar genome. Genome Biol. 7(7), 112 (2006).
6. Swan M. Emerging patient-driven healthcare models: an examination of health social networks, consumer personalized medicine and quantified self-tracking. Int. J. Environ. Res. Public Health 6(2), 492-525 (2009).